Alquest Announced as MedNet Solutions' First iMedNet CRO Partner

MINNETONKA, Minn., Oct. 18, 2011 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, and Alquest LLC, a CRO specializing in medical devices, in vitro diagnostics (IVDs), biologics and combination products, are pleased to jointly announce that Alquest has become the first organization to join the iMedNet™ CRO Partner Program.  Introduced last month by MedNet Solutions, the iMedNet CRO Partner Program helps Clinical Research Organizations (CROs) improve research efficiency, expand their service offerings, decrease internal costs and win more business.

"We're delighted to be the first iMedNet CRO Partner with MedNet Solutions," stated Linda Alexander, Chief Executive Officer of Alquest.  "Their new iMedNet EDC solution builds on the success of their proven ENLIGHTEN® software and brings eClinical capabilities to a whole new level.  I'm excited to show this to our clients and provide them with this comprehensive, state-of-the-art solution."

"iMedNet provides us with flexible, easy-to-use tools to reduce our database development timelines and effectively meet our clients' needs," noted Ann Quinlan-Smith, President of Alquest.  "iMedNet is an outstanding EDC solution for study sites as well, with simple screens and easy, yet complete navigation."

"We are extremely happy to have Alquest as our first iMedNet CRO Partner organization," commented John M. (Rob) Robertson, President and CEO of MedNet Solutions.  "Their long, proven track record, sterling reputation and strong focus on customer service are exactly what we are looking for in our CRO partners.  Alquest is just the type of quality organization that many prospective iMedNet customers are looking for to build and manage their studies."  

Please contact MedNet Solutions for more information on the iMedNet CRO Partner Program.

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, biotechnology, and contract research organizations on clinical research conducted around the world. MedNet delivers a superior customer experience from beginning to end.  For more information, please visit www.mednetstudy.com.

About Alquest LLC – a NAMSA Company

Alquest LLC is a NAMSA company.  Founded 17 years ago, Alquest supports medical device manufacturers in the areas of regulatory strategy and submissions; clinical trial design and trial conduct; quality systems; and product safety, biocompatibility and sterilization.  NAMSA is the world's leading medical device-focused contract research organization specialized in safety evaluations. For more information, see www.alquest.com and www.namsa.com

Contact Information:
Dirk H. Nelson
Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN  55305
USA
(763) 258-2735

Linda S. Alexander
Chief Executive Officer/Founder
Alquest LLC – a NAMSA Company
4050 Olson Memorial Highway, Suite 350
Minneapolis, MN  55422
USA
(763) 287-3830

SOURCE MedNet Solutions